GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

Moderna rises 3.45% in Tuesday's session

Published by Global Banking & Finance Review

Posted on November 3, 2026

1 min read
Add as preferred source on Google
MRNA 228.44 +3.45% last traded price, 3 Nov 2026
Previous close
220.83
Market cap
$90.6bn

Source: Eulerpool. The figures in this article were checked against this snapshot before publication.

Moderna's shares in the United States health care sector last traded at $228.44, 3.45% above their previous close of $220.83 on 3 November 2026. The company held a market value of $90.64bn during the session.

Last traded price228.44 USD
Previous close220.83 USD
Change from the previous close+3.45%
Market value$90.64bn

Prices of Moderna (MRNA), listed in United States, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 3 November 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 2 November 2026. Market value is converted to US dollars at the ECB reference rate. We report a stock the day it ends a session 2% or more away from its previous close, where the previous session's trading was worth at least US$5 million. Source: Eulerpool. How we compile these reports.

Moderna — daily MRNA Delayed

Related Articles

More from Markets

Explore more articles in the Markets category